The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens
Yi Ying Wu, Hung Chang Wu, Jia En Wu, Kuo Yen Huang, Shuenn Chen Yang, Si Xuan Chen, Chao Jung Tsao, Keng Fu Hsu, Yuh Ling Chen, Tse Ming Hong
Dive into the research topics of 'The dual PI3K/mTOR inhibitor BEZ235 restricts the growth of lung cancer tumors regardless of EGFR status, as a potent accompanist in combined therapeutic regimens'. Together they form a unique fingerprint.